| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $243K | — | -94.7% |
| Cost of Revenue | $202K | — | -94.5% |
| Gross Profit | $41K | — | -95.2% |
| R&D Expense | $39K | — | — |
| SG&A Expense | $1.8M | — | -33.2% |
| Operating Income | -$2.7M | — | -29.7% |
| Pre-tax Income | -$2.5M | — | -19.3% |
| Income Tax | $800 | — | +109.4% |
| Net Income | -$2.5M | — | -19.8% |
| EPS (Basic) | $0.00 | — | — |
| EPS (Diluted) | $0.00 | — | — |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.4M | +92.6% | -14.0% |
| Current Assets | $3.3M | +66.4% | -70.5% |
| Total Assets | $11.9M | +19.2% | -56.3% |
| Current Liabilities | $6.3M | -28.1% | -46.6% |
| Long-term Debt | $0 | — | — |
| Total Liabilities | $126.1M | +3.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Investing Cash Flow | -$574K | — | -598.7% |
| Financing Cash Flow | $6.0M | — | +130.8% |
| +2.4% |
| Stockholders' Equity | -$108.4M | -2.3% | -13.9% |